These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 5772859)

  • 1. Interaction between paraoxon and tri-o-tolyl phosphate in rats.
    Lauwerys RR; Murphy SD
    Toxicol Appl Pharmacol; 1969 Mar; 14(2):348-57. PubMed ID: 5772859
    [No Abstract]   [Full Text] [Related]  

  • 2. The inhibition of erythrocyte cholinesterase by tri-esters of phosphoric acid. I. Diethyl p nitrophenyl phosphate (E600) and analogues.
    ALDRIDGE WN; DAVISON AN
    Biochem J; 1952 Apr; 51(1):62-70. PubMed ID: 14944533
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of rat cholinesterase by tritolyl phosphates.
    COURSEY MM; DUNLAP MK; HINE CH
    Proc Soc Exp Biol Med; 1957 Dec; 96(3):673-5. PubMed ID: 13505825
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of tri-0-tolyl phosphate pretreatment on the toxicity and metabolism of parathion and paraoxon in mice.
    Lynch WT; Coon JM
    Toxicol Appl Pharmacol; 1972 Feb; 21(2):153-65. PubMed ID: 5023829
    [No Abstract]   [Full Text] [Related]  

  • 5. Retention of inhaled sarin vapor and its effect on red blood cell cholinesterase activity in man.
    Oberst FW; Koon WS; Christensen MK; Crook JW; Cresthull P; Freeman G
    Clin Pharmacol Ther; 1968; 9(4):421-7. PubMed ID: 5655475
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic treatment with cholinesterase inhibitors increases alpha 2-adrenoceptors in rat brain.
    Hollingsworth PJ
    Eur J Pharmacol; 1988 Aug; 153(2-3):167-73. PubMed ID: 2846316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dealkylation and loss of capacity for reactivation of cholinesterase inhibited by sarin.
    Harris LW; Fleisher JH; Clark J; Cliff WJ
    Science; 1966 Oct; 154(3747):404-7. PubMed ID: 5917091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Spontaneous reactivation of alkylphosphate-blocked (paraoxon, systox, isosytox) cholinesterase in vitro].
    FRIEDBERG KD; ERDMANN WD
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1959; 237():1-10. PubMed ID: 13825024
    [No Abstract]   [Full Text] [Related]  

  • 9. DNA adduct formation in Salmonella typhimurium, cultured liver cells and in Fischer 344 rats treated with o-tolyl phosphates and their metabolites.
    Mentzschel A; Vamvakas S; Dekant W; Henschler D
    Carcinogenesis; 1993 Oct; 14(10):2039-43. PubMed ID: 8222051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetylcholine content in the brain of rats treated with paraoxon and obidoxime.
    Milosević MP
    Br J Pharmacol; 1970 Aug; 39(4):732-7. PubMed ID: 5485148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibitory activities of tri-ortho-cresyl phosphate (TOCP) against cholinesterase and neurotoxic esterase].
    Kawai M; Iyatomi A; Kaneko Y
    Sangyo Igaku; 1984 Jan; 26(1):68-9. PubMed ID: 6482069
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of paraoxon (diethyl 4-nitrophenyl phosphate) on axone reflex sweating produced by alpha-lobeline.
    BACH JN; McLAUGHLIN JT; SONNENSCHEIN RR
    Experientia; 1961 Dec; 17():568-9. PubMed ID: 13863703
    [No Abstract]   [Full Text] [Related]  

  • 13. Penetration of neostigmine, physostigmine, and paraoxon into the squid giant axon.
    Brzin M; Dettbarn WD; Rosenberg P
    Biochem Pharmacol; 1965 Jun; 14(6):919-24. PubMed ID: 5835871
    [No Abstract]   [Full Text] [Related]  

  • 14. Return of cholinesterase activity in the rat after inhibition by organophosphorus compounds. I. Diethyl p-nitro-phenyl phosphate (E 600, paraoxon).
    DAVISON AN
    Biochem J; 1953 Jul; 54(4):583-90. PubMed ID: 13058955
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the effect of paraoxon on the electrical activity of efferent cervical sympathetic nerves and the blood pressure of rats].
    Kuga T; Erdmann WD
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 258(5):457-70. PubMed ID: 4232486
    [No Abstract]   [Full Text] [Related]  

  • 16. Differential muscarinic receptor binding of acetylcholinesterase inhibitors in rat brain, human brain and Chinese hamster ovary cells expressing human receptors.
    Van Den Beukel I; Dijcks FA; Vanderheyden P; Vauquelin G; Oortgiesen M
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1113-9. PubMed ID: 9190843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative measurement of inhibition of aliesterases, acylamidase, and cholinesterase by EPN and Delnav.
    DuBois KP; Kinoshita FK; Frawley JP
    Toxicol Appl Pharmacol; 1968 Mar; 12(2):273-84. PubMed ID: 4299018
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of brain cholinesterase activity after the injection of organophosphorus compounds in the rat.
    Reiff B
    Br J Pharmacol; 1970 Sep; 40(1):135P-136P. PubMed ID: 5487003
    [No Abstract]   [Full Text] [Related]  

  • 19. The influence of DFP, atropine and pyridinium aldoximes on the rate of clearance of diisopropyl phosphate (DI32P) from the mouse circulatory system.
    Ramachandran BV
    Biochem Pharmacol; 1967 Nov; 16(11):2061-8. PubMed ID: 4229543
    [No Abstract]   [Full Text] [Related]  

  • 20. Lipid changes in tri-o-cresylphosphate-induced neuropathy.
    Morazain R; Rosenberg P
    Toxicol Appl Pharmacol; 1970 Mar; 16(2):461-74. PubMed ID: 5435615
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.